↓ Skip to main content

Cochrane Database of Systematic Reviews

Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
8 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
135 Mendeley
Title
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia
Published in
Cochrane database of systematic reviews, July 2014
DOI 10.1002/14651858.cd009268.pub2
Pubmed ID
Authors

Magdolna Tardy, Maximilian Huhn, Werner Kissling, Rolf R Engel, Stefan Leucht

Abstract

Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between antipsychotic compounds, however, low-potency antipsychotic drugs are often clinically perceived as less efficacious than high-potency compounds, and they also seem to differ in their side-effects.

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
South Africa 1 <1%
Unknown 132 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 19%
Student > Bachelor 17 13%
Researcher 15 11%
Student > Ph. D. Student 12 9%
Student > Doctoral Student 9 7%
Other 23 17%
Unknown 33 24%
Readers by discipline Count As %
Medicine and Dentistry 38 28%
Psychology 19 14%
Nursing and Health Professions 11 8%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Social Sciences 5 4%
Other 17 13%
Unknown 37 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2022.
All research outputs
#1,643,637
of 22,631,715 outputs
Outputs from Cochrane database of systematic reviews
#3,743
of 12,292 outputs
Outputs of similar age
#16,337
of 204,410 outputs
Outputs of similar age from Cochrane database of systematic reviews
#58
of 192 outputs
Altmetric has tracked 22,631,715 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,292 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.2. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,410 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 192 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.